Axsome Therapeutics, Inc. Revenue 2022–2025
Axsome Therapeutics, Inc. annual/quarterly revenue history and growth rate from 2022 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Axsome Therapeutics, Inc. revenue for the quarter ending March 31, 2026 was 191.2 M, a 57.42% increase year-over-year.
- Axsome Therapeutics, Inc. revenue for the twelve months ending March 31, 2026 was 633.7 M, a 95.15% increase year-over-year.
- Axsome Therapeutics, Inc. annual revenue for 2025 was 638.5 M, a 65.55% increase from 2024.
- Axsome Therapeutics, Inc. annual revenue for 2024 was 385.7 M, a 42.53% increase from 2023.
- Axsome Therapeutics, Inc. annual revenue for 2023 was 270.6 M, a 440.80% increase from 2022.
- Axsome Therapeutics, Inc. annual revenue for 2022 was 50.0 M.
Axsome Therapeutics, Inc. (AXSM) — Frequently Asked Questions
Axsome Therapeutics, Inc. (AXSM) is a publicly traded US company. It has a market capitalization of $12.58B. In fiscal 2025 it reported revenue of $638M and net income of -$183M. Explore AXSM's stock price, financial statements, earnings history, margins and key ratios below.
What is Axsome Therapeutics, Inc.'s market cap?
Axsome Therapeutics, Inc. (AXSM) has a market capitalization of $12.58B.
What is the AXSM stock price?
AXSM trades at $252.85 (+2.64% on the day).
How much revenue does Axsome Therapeutics, Inc. make?
Axsome Therapeutics, Inc. reported revenue of $638M in fiscal 2025.
Is AXSM profitable?
In fiscal 2025, Axsome Therapeutics, Inc. reported net income of -$183M.